People

Assembling and maintaining the information on this site depends on support from large numbers of experts in the field. We would like to acknowledge the contributions of those listed here.

WHO Secretariat

Dr Ana Maria Henao-Restrepo
Ximena Riveros de Laurie
Neddy Mafunga

Pneumococcal vaccines: collaborators

Agence de Médecine Preventive, France
Brad Gessner
Jennifer Moisi
Berthe Njanpop

Beijing Children’s Hospital, China
Yonghong Yang

Bill and Melinda Gates Foundation
Richard Adegbola

Bocconi University, Italy
Alessia Melegaro

Centers for Disease Control and Prevention, USA
Bernard W Beall
Karen Rudolph

Center for State Control of Drugs, Cuba
Julie Escota López

Chris Hani-Baragwanath Hospital
Peter V Adrian
Shabir Madhi

Emory University, USA
Claire Broome
Keith P Klugman

Federal Agency for Medicines and Health, Belgium
Pieter Neels

Fondation Merieux, France
Glaucia Paranhos-Baccala
Institut Pasteur
Judith Mueller

John Hopkins Bloomberg School of Public Health, USA
Laura Hammit
Orin Levine
Kate O’Brien

Institute of Technology Chemical and Biological, Portugal
Raquel Sa-leao

Karolinska Institute, Sweden
Birgitta Henriques-Normark

KEMRI Wellcome Trust Research Programme, Kenya
Anthony Scott

London School of Hygiene and Tropical Medicine, UK
Paul Fine
Kim Mulholland
Colin Sanderson

Mahidol Oxford Tropical Medicine Research, UK
Paul Turner

Medical Research Council Unit, The Gambia
Martin Antonio

Menzies School of Health Research, Australia
Kim Hare
Amanda Leach

MRC International Nutrition Group
Grant Mackenzie

Murdoch Children’s Research Institute, Australia
Catherine Satzke
Barbara Porter

National Agency for Food and Drug Administration and Control, Nigeria
Beno Nyam Yakubu

National Agency of Drug and Food Control, Indonesia
Endang Woro Tedjowati

National Institute for Biological Standards and Control, UK
Ian Feavers

National Institute for Health and Welfare, Finland
Kari Auranen
Jukka Jokinen
Helena Käyhty
Hanna Nohynek
Birgit Simell
Sanna Tossavainen
Anni virolainen-Julkunen

National Institute of Health, USA
Farukh Khambaty

Norwegian Institute of Public Health
Didrik Vestrheim

Papua New Guinea Institute of Medical Research
Andrew Greenhill

Pneumococcal Vaccine Project
Mark Alderson

Soroka University Medical Center, Israel
Ron Dagan

South African Medicines Control Council
James Southern

Swedish Institute for Communicable Disease Control
Ingrid Uhnoo

University College London Medical School, UK
David Goldblatt

University of Bern, Switzerland
Nicola Low
Pippa Scott

University of California, USA
Arthur Reingold

University of Havana, Cuba
Vicente Verez Bencomo

University of Melbourne, Australia
Fiona Russell

University of Pennsylvania, USA
Jeffrey N Weiser

Utrecht University, the Netherlands
Debby Bogaert
Lieke Sanders

Wake Forest University
Jennifer Loo
Cynthia Whitney

Nigel Gay

Rotavirus vaccines: collaborators

Bill and Melinda Gates Foundation
Duncan Steele

Centers for Disease Control and Prevention, USA
Manish Patel
Umesh Parashar
Melinda Wharton

Chris Hani-Baragwanath Hospital, South Africa
Shabir Madhi

Christian Medical College, India
Gagandeep Kang

Enhance Reviews, UK
Karla Soares-Weiser

Jordan University
Najwa Khuri-Bulos

Liverpool School of Tropical Medicine, UK
Paul Garner

London School of Hygiene and Tropical Medicine, UK
Andrew Clark
Paul Fine
Colin Sanderson

Ontario Agency for Health Protection, Canada
Shelley Deeks

Programme for Appropriate Technology in Health (PATH), USA
Deborah Atherly

Redeemer’s University, Nigeria
Oyewale Tomori

Swiss Tropical and Public Health Institute
Javier Bosch-Capblanch

Wake Forest University, USA
Jon S Abramson

Robin Biellik

Haemophilus Influenzae type b vaccines: collaborators

Agence de Médecine Préventive, France
Brad Gessner

Centers for Disease Control and Prevention, USA
Rana Hajjeh

Emory University, USA
Walter Orenstein

Gavi Alliance
Hope Johnson

Hospital del Niño Roberto del Rio, Chile
Rossana Lagos

Johns Hopkins School of Public Health, USA
Mathuram Santosham
Neff Walker
James Watt

London School of Hygiene and Tropical Medicine, UK
Andrew Clark
Paul Fine
Ulla Griffiths
Charlotte Jackson
Punam Mangtani
Kim Mulholland

University of Bern, Switzerland
Pippa Scott

Wake Forest University, USA
Jon S Abramson

A three-person management team (MT), including the Principal Investigator at WHO and two persons representing the University of Bern (Prof Mathias Egger) and the London School of Hygiene and Tropical Medicine (Prof Paul Fine), has been established to ensure that the aims and objectives of the project are met.

Quality Data

The systematic reviews provide an up-to-date, thorough, yet abridged view of the evidence for selected vaccines and immunization schedules.

Management Team

A three-person management team from WHO, the University of Bern and the London School of Hygiene and Tropical Medicine has been established to ensure that the aims and objectives of the project are met.